Cell Signalling - Translational Cancer Research Group

As personalised medicine represents the future for cancer therapy, there is a need of further understanding the molecular basis of cancer and develop better diagnostic tools. The Giamas laboratory focuses on the identification and elucidation of the role of proteins implicated in the progression of cancer and the development of novel therapeutic targets.

Our translational research laboratory combines a variety of molecular, cellular and biochemical techniques along with established in vitro/in vivo models and patients' specimens to study relevant pathways in cancer.

In aggregate, our research links ‘bench work to bedside’ and can have an enormous impact to patients while at the same time supporting the entire scientific community.

Contact

Prof Georgios Giamas

Georgios Giamas photo

Professor of Cancer Cell Signalling Head of Department for Biochemistry and Biomedicine UOA5 lead for REF2021

University of Sussex
John Maynard Smith Building
Falmer, Brighton, BN1 9QG Email: g.giamas@sussex.ac.uk Tel: +44 (0) 1273 873163

Also, Visiting Professor Imperial College Faculty of Medicine Department of Surgery and Cancer Hammersmith Hospital Campus London, W12 0NN, UK Email: g.giamas@imperial.ac.uk

Founder & Chief Scientific Officer of Stingray Bio Email: georgios@stingraybio.com https://www.stingraybio.com

Editor in Chief, Cancer Gene Therapy https://www.nature.com/cgt/

Associate Editor, Oncogene http://www.nature.com/onc/about.html

Editorial Board, Communications Biology https://www.nature.com/commsbio/about/editorial-board

https://orcid.org/0000-0002-4417-2707

Visit Prof Georgios Giamas Biochemistry faculty profile

Giamas Lab